Shell Asset Management Co
- SEC CIK
- 0001211028
- Latest filing
- Nov 7, 2025
FATE holding history
Fate Therapeutics Inc in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FATE overviewAll 13F holders of FATEFull Q3 2025 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −1−100.0% | Sold out | Holders |
| Q4 2024 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1 | $0 | 0.0% | – | No prior filing | Holders |
| Q2 2024 | – | – | – | – | Not filed | Holders |
| Q1 2024 | 1 | $0 | 0.0% | −59,301−100.0% | Reduced | Holders |
| Q4 2023 | 59,302 | $222.0K | <0.1% | −17,897−23.2% | Reduced | Holders |
| Q3 2023 | 77,199 | $164.0K | <0.1% | +73,456+1,962.5% | Added | Holders |
| Q2 2023 | 3,743 | $18.0K | <0.1% | −21−0.6% | Reduced | Holders |
| Q1 2023 | 3,764 | $21.0K | <0.1% | −13−0.3% | Reduced | Holders |
| Q4 2022 | 3,777 | $38.0K | <0.1% | −765−16.8% | Reduced | Holders |
| Q3 2022 | 4,542 | $102.0K | <0.1% | −1,190−20.8% | Reduced | Holders |
| Q2 2022 | 5,732 | $142.0K | <0.1% | +9+0.2% | Added | Holders |
| Q1 2022 | 5,723 | $222.0K | <0.1% | −848−12.9% | Reduced | Holders |
| Q4 2021 | 6,571 | $384.0K | <0.1% | +36+0.6% | Added | Holders |
| Q3 2021 | 6,535 | $387.0K | <0.1% | −290−4.2% | Reduced | Holders |
| Q2 2021 | 6,825 | $592.0K | <0.1% | +6,825 | New | Holders |